Multiple studies have shown that cytotoxic CD8+ T cells are required for RT-induced tumor control in mouse breast cancer (4T1), melanoma (B16), lymphoma (EL4), and lung cancer (98, 99). This evidence concerns the gene CD8A and neoplasm.